JeffreyNBruceMD

Brain & Spinal Tumor, Pituitary Surgery, Skull Base

Professor of Neurological Surgery, Columbia P&S

Overview of Dr. Bruce

Dr. Jeffrey Bruce is a neurosurgeon in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and Lenox Hill Hospital. He received his medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 34 years. Dr. Bruce accepts several types of health insurance, listed below. He is one of 130 doctors at New York-Presbyterian Hospital and one of 55 doctors at Lenox Hill Hospital who specialize in Neurosurgery. He has more than 100 publications and over 500 citings.

Office
710 W 168th St
Neurological Institute, Room 434
New York, NY 10032
Book by Phone+1(415) 799-3708

Fax+1 212-305-7346

Education & Training

New York Presbyterian Hospital (Columbia Campus)Residency, Neurological Surgery, 1985 - 1990
Clinical Center at the National Institutes of HealthResidency, Neurological Surgery, 1984 - 1985
New York Presbyterian Hospital (Columbia Campus)Internship, Transitional Year, 1983 - 1984
Rutgers Robert Wood Johnson Medical SchoolClass of 1983

Certifications & Licensure

NY State Medical License 1989 - 2026
NJ State Medical License 1993 - 2025
American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2004-2020
New York Magazine: Top Doctors Castle Connolly, 2002-2008, 2011-2014, 2017-2020
America's Top Doctors for Cancer Castle Connolly, 2005-2020
Top Doctors: New York Metro Area Castle Connolly, 2002-2020
Super Doctor SuperDoctors.com
Fellow (FACS) American College of Surgeons
Fellow (FAANS) American Association of Neurological Surgeons
Join now to see all

Clinical Trials

Safety Study of Intracerebral Topotecan for Recurrent Brain Tumors Start of enrollment: 2004 Mar 01
Unknown status
Phase 1, Phase 2
A Phase I Study of Topotecan by Convection Enhanced Delivery (Intracerebral Clysis) for the Treatment of Recurrent Primary Malignant Brain Tumors Start of enrollment: 2003 Sep 01
A Phase I/II Study of Topotecan by Intracerebral Clysis for the Treatment of Recurrent Primary Malignant Brain Tumors Start of enrollment: 2003 Oct 01
Prospective Study of Clinically Nonfunctioning Pituitary Adenomas Start of enrollment: 2010 Nov 01
Recruiting
Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery Start of enrollment: 2013 May 01
Terminated
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Join now to see all

Publications & Presentations

PubMed

Biologically informed deep neural networks provide quantitative assessment of intratumoral heterogeneity in post treatment glioblastoma.
Hairong Wang, Michael G Argenziano, Hyunsoo Yoon, Deborah Boyett, Akshay Save
NPJ Digital Medicine. 2024-10-19
Targeted delivery of napabucasin with radiotherapy improves outcomes in diffuse midline glioma.
Matthew Gallitto, Xu Zhang, Genesis De Los Santos, Hong-Jian Wei, Ester Calvo Fernández
Neuro-Oncology. 2024-10-12
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas.
Connor J Kinslow, Soumyajit Roy, Fabio M Iwamoto, Paul D Brown, David M DeStephano
Neuro-Oncology. 2024-10-03

Journal Articles

De Novo Gene Signature Identification from Single‐Cell RNA‐Seq with Hierarchical Poisson Factorization
Peter Canoll, Jeffrey N Bruce, Molecular Systems Biology

Authored Content

Recently Viewed (1) Article Information Headings References TrendMD Related Metrics PubMed Google ScholarDecember 2018
Effectiveness of Perioperative Antiepileptic Drug Prophylaxis for Early and Late Seizures Following Oncologic Neurosurgery: A Meta-Analysis RelatedApril 2018
Effectiveness of Perioperative Antiepileptic Drug Prophylaxis for Early and Late Seizures Following Oncologic Neurosurgery: A Meta-AnalysisApril 2018

Press Mentions

Implant Delivers Chemo Directly to Brain in Patients Battling Brain TumorsNovember 22nd, 2022
Brain Cancer Implant Is Shown to Safely Deliver Chemotherapy Directly to the OrganNovember 16th, 2022
Implanted Pump Safely Delivered Chemo Straight to the Brain in Patients with Brain CancerNovember 10th, 2022
Join now to see all

Grant Support

Topotecan By Intracerebral Clysis For Brain TumorsNational Cancer Institute2002–2006
Topotecan By Intracerebral Clysis /Treatment Of Primary Malignant BraintumorNational Center For Research Resources2005
Recombinant Chimeric Protein For Recurrent AstrocytomaNational Center For Research Resources2000–2002
Intratumoral/Interstitial Therapy With Hn-6600 In Refracotry GlioblastomaNational Center For Research Resources1998–2000
CNS Consortium--New Approaches To Brain Tumor TherapyNational Cancer Institute1995–1997
Brain Tumor Research CenterNational Cancer Institute1995
CNS Consortium--New Approaches To Brain Tumor TherapyNational Cancer Institute1994
Brain Tumor Research CenterNational Cancer Institute1994

Professional Memberships

Congress of Neurological Surgeons - CNS
Member
American Society of Clinical Oncology - ASCO
Member
American Association of Neurological Surgeons - AANS
Fellow
New York Society for Neurosurgery
Member
American College of Surgeons - ACS
Member

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Texas BlueChoice
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First Choice
Great West PPO
Health Net Oregon PPO
Humana ChoiceCare Network PPO
Lifewise Health Plan of Oregon
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
ODS Network
Oxford Health Freedom
Oxford Health Liberty
Pacificare HMO
PacificSource Preferred PSN
Providence Health System Personal Option
Providence Health System Preferred PPO
Regence Oregon - Preferred Provider Network
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment